Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Dancin' deaminase.

Harris RS, Matsuo H.

Nat Struct Mol Biol. 2006 May;13(5):380-1.

PMID:
16738602
2.

APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA.

Chelico L, Pham P, Calabrese P, Goodman MF.

Nat Struct Mol Biol. 2006 May;13(5):392-9. Epub 2006 Apr 23.

PMID:
16622407
3.

DNA deaminases AID and APOBEC3G act processively on single-stranded DNA.

Pham P, Chelico L, Goodman MF.

DNA Repair (Amst). 2007 Jun 1;6(6):689-92; author reply 693-4. Epub 2007 Feb 8. No abstract available.

PMID:
17291835
4.

Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.

Luo K, Wang T, Liu B, Tian C, Xiao Z, Kappes J, Yu XF.

J Virol. 2007 Jul;81(13):7238-48. Epub 2007 Apr 11.

5.

Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.

Bishop KN, Holmes RK, Malim MH.

J Virol. 2006 Sep;80(17):8450-8.

6.

Selective inhibition of Alu retrotransposition by APOBEC3G.

Hulme AE, Bogerd HP, Cullen BR, Moran JV.

Gene. 2007 Apr 1;390(1-2):199-205. Epub 2006 Sep 27.

7.

APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.

Holmes RK, Koning FA, Bishop KN, Malim MH.

J Biol Chem. 2007 Jan 26;282(4):2587-95. Epub 2006 Nov 22.

8.

The nuclear DNA deaminase AID functions distributively whereas cytoplasmic APOBEC3G has a processive mode of action.

Coker HA, Petersen-Mahrt SK.

DNA Repair (Amst). 2007 Feb 4;6(2):235-43. Epub 2006 Dec 8.

PMID:
17161027
9.

Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.

Beale RC, Petersen-Mahrt SK, Watt IN, Harris RS, Rada C, Neuberger MS.

J Mol Biol. 2004 Mar 26;337(3):585-96.

PMID:
15019779
10.

APOBEC3G & HTLV-1: inhibition without deamination.

Strebel K.

Retrovirology. 2005 May 29;2:37.

11.

Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms.

Ara A, Love RP, Chelico L.

PLoS Pathog. 2014 Mar 20;10(3):e1004024. doi: 10.1371/journal.ppat.1004024. eCollection 2014 Mar.

12.

[Subcellular localization of APOBEC3G by confocal laser scanning microscope (CLSM)].

Yang YS, Li L, Li ZL, Zeng Y.

Bing Du Xue Bao. 2007 Jan;23(1):16-21. Chinese.

PMID:
17886715
13.

The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain.

Haché G, Liddament MT, Harris RS.

J Biol Chem. 2005 Mar 25;280(12):10920-4. Epub 2005 Jan 12.

14.

Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.

Jost S, Turelli P, Mangeat B, Protzer U, Trono D.

J Virol. 2007 Oct;81(19):10588-96. Epub 2007 Jul 25.

15.

N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.

Lei YC, Tian YJ, Ding HH, Wang BJ, Yang Y, Hao YH, Zhao XP, Lu MJ, Gong FL, Yang DL.

World J Gastroenterol. 2006 Dec 14;12(46):7488-96.

16.

Retroviral restriction by APOBEC proteins.

Harris RS, Liddament MT.

Nat Rev Immunol. 2004 Nov;4(11):868-77. Review.

PMID:
15516966
17.

Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.

Wichroski MJ, Robb GB, Rana TM.

PLoS Pathog. 2006 May;2(5):e41. Epub 2006 May 12.

18.

Advantages and disadvantages of cytidine deamination.

Cascalho M.

J Immunol. 2004 Jun 1;172(11):6513-8. Review.

19.

APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.

Suspène R, Sommer P, Henry M, Ferris S, Guétard D, Pochet S, Chester A, Navaratnam N, Wain-Hobson S, Vartanian JP.

Nucleic Acids Res. 2004 Apr 30;32(8):2421-9. Print 2004.

20.

APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.

Pion M, Granelli-Piperno A, Mangeat B, Stalder R, Correa R, Steinman RM, Piguet V.

J Exp Med. 2006 Dec 25;203(13):2887-93. Epub 2006 Dec 4.

Supplemental Content

Support Center